Resources
Filter by Topic
- Press Releases
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
- News & Events
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named IHD’s Data Science module as...
- Blogs
Q&A with Dr. Mark Friedman
- Publication
Podium and posters presented at Virtual ISPOR Europe 2020 November 16th - 19th.
- Blogs
By Matthew Sussman, MA
- News & Events
Virtual ISPOR Europe, November 16th - 19th
- Publication
Podium and posters at ICPE All Access Virtual Meeting, September 16-17, 2020.
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 2)
In our previous blog post, we sat down with Dr. Samy Suissa, the co-founder and principal investigator of the Canadian Network for Observational Drug Effect Studies,
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 1)
Randomized control trials (RCTs) are typically heralded as the gold standard in clinical trial design. However, regulatory agencies are increasingly recognizing the role of single-arm
Using Machine Learning in the Evolving Landscape of Real-World Data
In this article with HIT Consultant, Zeynep Icten, PhD, (Director of Data Science Solutions at Panalgo) discusses the predictive power of machine learning for healthcare
Webinar – Preparing a Successful ICER Strategy: Lessons from the Frontlines
How do you prepare for a successful ICER strategy? We asked three industry experts what the key components of a successful ICER evaluation strategy are
Panalgo to Present at ISPOR Europe 2021
Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database. Zeynep Icten, MS,
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
September 28, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization